Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas
Superior HealthPlan and eFamilyCare today announced a partnership to support family caregivers as they care […]
Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform
Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced a […]
$25 Million Gift to Penn Medicine and Children's Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders
A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of […]
Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Huma Therapeutics, a leading global digital health company, today announced a partnership with Camden Health […]
Avita Care Solutions Names Dr. Christopher Hall First Chief Medical Officer
Avita Care Solutions, a national healthcare services organization committed to providing comprehensive, compassionate, and inclusive […]
Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer
Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, […]
Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth
Spectrum Science, an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech […]
Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer
Synergy Health Partners, a leader in specialized hospital staffing and management models that improve access […]
TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces the final close of […]
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more